Equity
€2,500 from €195,613 in 2024
Equity fell by 99% in 1 year.
Dr Vanaubel
Lifetime
4 annual accounts with figures on one time axispeak €151,298 (2024)
€145,772▼ 3.7%
peak €114,219 (2024)
€108,716▼ 4.8%
peak €195,613 (2024)
€2,500▼ 98.7%
€308,685▲ 624%
Board1 name since 2022
1 directorVANAUBEL Régis Francis Charles Ghislain
Documentsfilings and deeds
26-06-202635 days before the deadline
2025micro format
Dividend €301,829Equity from €195,613 to €2,500Debts from €42,632 to €308,685Cash from €99,013 to €276,390
Key points
from the 2025 annual accountsTurnover
≈ €370,000 estimated
The micro format states no turnover.
Debts
€308,685 99% of the balance sheet
Suppliers 1%Taxes and wages 25%Other 74%
Liquidity
0.93 was 5.03 in 2024
Short-term debts rose from €41,870 to €308,685.
Filings
4 annual accounts 2 late
The 2023 accounts came latest: 28 days after the end of the period.
Starting capital
€2,500 100 shares
Checked score
87
Excellent
Financially stronger than 36% of micro companies without a NACE code
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.3%
01-2025: 0.3%● unchanged vs 12-2024
02-2025: 0.3%● unchanged vs 01-2025
03-2025: 0.3%● unchanged vs 02-2025
04-2025: 0.3%● unchanged vs 03-2025
05-2025: 0.3%● unchanged vs 04-2025
06-2025: 0.3%● unchanged vs 05-2025
07-2025: 0.3%● unchanged vs 06-2025
08-2025: 0.6%▲ +0.3 percentage points vs 07-2025highest value
09-2025: 0.1%▼ -0.5 percentage points vs 08-2025
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025lowest value
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026
08-2026: 0.2%▲ +0.1 percentage points vs 07-2026
09-2026: 0.2%● unchanged vs 08-2026
10-2026: 0.2%● unchanged vs 09-2026
11-2026: 0.2%● unchanged vs 10-2026
Financial strengthAverage
Score breakdown
raises risk
Founded in 2022
lowers risk
Size: total assets €311,185
Liquidity: current ratio 0.93, cash €276,390
No main activity registered
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 16% of them on solvency, 35% on liquidity, 90% on profitability and 3% on growth.
The bankruptcy probability was computed on 05-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 2,157 companies had the same profile as Dr Vanaubel has now. Each dot stands for 6 companies, two years later.
94.1%
were still trading
2.8%
stopped another way
3.0%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of Dr Vanaubel itself is lower: 0.2% within 12 months. It rests on far more data about Dr Vanaubel than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,157 companies, not a prediction for Dr Vanaubel. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-06-2026, 35 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
35 days early
2024
8 days late
2023
28 days late
2022
25 days early
← before the deadline
after the deadline →
tick = median of all Belgian filings
The company filed its last 4 accounts on average 6 days before the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 23 July (3 of the last 4 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
06-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
- VANAUBEL Régis Francis Charles Ghislain 100 sharesdeed of 16-09-2022
Recent changes
First establishment
Rue Joseph Muller 46, Dalhem
Incorporation
Founding capital of €2,500, 100 shares · Founder: VANAUBEL Régis Francis Charles Ghislain · Appointment: VANAUBEL Régis Francis Charles Ghislain (director) · published on 16-09-2022 · Gazette deed
Official details
Source: KBO- Status
- Active since 14-09-2022Normal situation
- Activity
- “L'exercice de la médecine,et en particulier l’activité de médecin généraliste,par le ou les actionnaires…” (deed in French)From the articles, 6 activitiesNo NACE code in the KBO yet
- Establishment unit
- 2.336.091.9764608 Dalhem, since 01-10-2022
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Annual accounts 2025
- €311,185▲ 30.6%
- Filing
- Filed on 26-06-2026, 35 days before the end of the filing period
Insights on Dr Vanaubel
Dr Vanaubel files the micro format. That format states no turnover. The gross margin rose from €10,573 in 2022 to €145,772 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Dr Vanaubel
- What is the company number of Dr Vanaubel?
- The company number of Dr Vanaubel is 0790.794.379. The VAT number is the same number with BE in front: BE 0790.794.379.
- Where is Dr Vanaubel based?
- The registered office is at Rue Joseph Muller 46, 4608 Dalhem.Company details
- What is the legal form of Dr Vanaubel?
- Dr Vanaubel is a private limited company (BV).
- When was Dr Vanaubel founded?
- Dr Vanaubel was founded on 14-09-2022.
- Is Dr Vanaubel still active?
- Yes, Dr Vanaubel is an active enterprise in the KBO register.
- What is the turnover of Dr Vanaubel?
- The turnover in financial year 2025 is ≈ €370,000. This figure is estimated from the gross margin of €145,772 and 2,211 comparable companies of the same size. It probably lies between €240,000 and €560,000. It is a rough estimate.Financials
- Is Dr Vanaubel profitable?
- In financial year 2025, Dr Vanaubel made a profit of €108,716.
- Where can I find the annual accounts of Dr Vanaubel?
- Dr Vanaubel filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Dr Vanaubel due?
- Dr Vanaubel must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.